Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Moderna, Inc. (MRNA)
Sector: Healthcare; Industry: Biotechnology

Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Moderna, Inc. also has a collaboration with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-13 Bancel Stephane Chief Executive Officer Sell 19,000 $219.77 $4,175,690 No
2022-01-13 Hoge Stephen President Sell 20,000 $219.67 $4,393,450 Yes
2022-01-06 Bancel Stephane Chief Executive Officer Sell 19,000 $223.27 $4,242,200 No
2021-12-31 Andres Juan nan Sell 5,000 $249.88 $1,249,400 Yes
2022-01-03 Hoge Stephen President Sell 20,000 $247.08 $4,941,600 Yes
2021-12-30 Bancel Stephane Chief Executive Officer Sell 10,000 $243.42 $2,434,200 No
2021-12-29 Andres Juan nan Sell 5,000 $240.00 $1,200,000 Yes
2021-12-29 Bancel Stephane Chief Executive Officer Sell 9,000 $240.00 $2,160,000 No
2021-12-27 Andres Juan nan Sell 10,000 $243.10 $2,431,000 Yes
2021-12-23 Hoge Stephen President Sell 15,000 $247.30 $3,709,548 Yes
2021-12-23 Bancel Stephane Chief Executive Officer Sell 10,000 $250.41 $2,504,100 No
2021-12-22 Andres Juan nan Sell 5,000 $264.26 $1,321,300 Yes
2021-12-22 Bancel Stephane Chief Executive Officer Sell 9,000 $264.26 $2,378,340 No
2021-12-15 Andres Juan nan Sell 5,000 $272.11 $1,360,550 Yes
2021-12-16 Bancel Stephane Chief Executive Officer Sell 19,000 $278.47 $5,290,990 No
2021-12-13 Hoge Stephen President Sell 20,000 $257.01 $5,140,200 Yes
2021-12-09 Bancel Stephane Chief Executive Officer Sell 19,000 $283.84 $5,393,050 No
2021-12-06 Andres Juan nan Sell 20,000 $290.05 $5,801,000 Yes
2021-12-03 Hoge Stephen President Sell 20,000 $309.85 $6,196,900 Yes
2021-12-02 Bancel Stephane Chief Executive Officer Sell 19,000 $314.85 $5,982,090 No
2021-11-29 Bancel Stephane Chief Executive Officer Sell 10,000 $319.62 $3,196,200 No
2021-11-29 Andres Juan nan Sell 10,000 $345.00 $3,450,000 Yes
2021-11-24 Andres Juan nan Sell 5,000 $273.01 $1,365,050 Yes
2021-11-17 Andres Juan nan Sell 5,000 $234.57 $1,172,850 Yes
2021-11-18 Bancel Stephane Chief Executive Officer Sell 19,000 $240.53 $4,570,030 No
2021-11-15 Andres Juan nan Sell 10,000 $228.44 $2,284,350 Yes
2021-11-10 Andres Juan nan Sell 5,000 $230.00 $1,150,000 Yes
2021-11-11 Bancel Stephane Chief Executive Officer Sell 19,000 $228.77 $4,346,700 No
2021-11-08 Andres Juan nan Sell 20,000 $234.85 $4,696,950 Yes
2021-11-03 Andres Juan nan Sell 5,000 $350.00 $1,750,000 Yes

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.